Molecular Oncology Survey
To better serve hospitals and physicians with patient treatment, we would like your input again regarding Hematologic Oncology Sequencing testing. To aid in providing this input, we are conducting a brief survey. The questionnaire should take less than two minutes to complete.
Complete Our Short Survey
Versiti provides innovative diagnostic and prognostic testing in blood cancers to support patient stratification and therapeutic decisions. We deliver novel testing services that provide critical clinical direction in complex cases of acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and chronic myelogenous leukemia (CML). Our testing menus are built around testing algorithms as recommended by the National Comprehensive Cancer Network (NCCN) and the World Health Organization (WHO).